Stay updated with breaking news from முடிவு பரிசோதனை. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
To print this article, all you need is to be registered or login on Mondaq.com. In December, the SEC filed a complaint against Decision Diagnostics and its CEO, Keith Berman, for falsely claiming the company had developed a finger prick blood test that could instantaneously detect COVID-19. As stated in its complaint, the SEC temporarily suspended trading of Decision Diagnostics securities on April 23, 2020. Now, investors have brought suit as well. Three institutional investors claim the company – which was already in financial distress as a result of alleged misappropriations by Berman – falsely disclosed it was developing an at-home COVID-19 test nearing ....
Health Care Enforcement Update: Covid-19 Fraud Cases Brought By DOJ And Private Plaintiffs | Mintz - Health Care Viewpoints jdsupra.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from jdsupra.com Daily Mail and Mail on Sunday newspapers.
Covid-19 Fraud Cases Brought By DOJ And Private Plaintiffs natlawreview.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from natlawreview.com Daily Mail and Mail on Sunday newspapers.
Decision Diagnostics Saga Continues as Investors Bring Suit | Proskauer - Corporate Defense and Disputes jdsupra.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from jdsupra.com Daily Mail and Mail on Sunday newspapers.
Home / Top News / DECN FINAL DEADLINE: ROSEN, A LEADING LAW FIRM, Encourages Decision Diagnostics Corp. Investors to Secure Counsel Before Important Tuesday Deadline in Securities Class Action – DECN DECN FINAL DEADLINE: ROSEN, A LEADING LAW FIRM, Encourages Decision Diagnostics Corp. Investors to Secure Counsel Before Important Tuesday Deadline in Securities Class Action – DECN NEW YORK, March 14, 2021 (GLOBE NEWSWIRE) WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Decision Diagnostics Corp. (OTC: DECN) between March 3, 2020 and December 17, 2020, inclusive (the “Class Period”), of the important March 16, 2021 lead plaintiff deadline. SO WHAT: If you purchased Decision Diagnostics securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement. ....